Headquarters: San Francisco, California, United States
52 week low:0.12
52 week high:175
Next ER:November 18, 2019
Top Stories (JAGX)
Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Talk about Jaguar Health Inc. below in comments section below.
Do you think you'll buy? Do you already have active trades now?
Stock Dividend Calendar.
Tips on researching about the company.
Try to do a SWOT analysis on them to find out about their S.W.O.T stands for Strength, Weakness, Opportunities and threats. Learn more about it via Investopedia. https://www.investopedia.com/terms/s/swot.asp
In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.